Curbing the influence of the drug industry: a British view

Smith explores the implications of a recent report from Britain's House of Commons Health Committee that examined the pharmaceutical industry's influence upon medicine. A recent report from politicians in Britain recommends a fundamental review of drug development, marketing, and prescribi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2005-09, Vol.2 (9), p.e241-e241
1. Verfasser:	Smith, Richard
Format:	Artikel
Sprache:	eng
Schlagworte:	Advisory Committees Attitude of Health Personnel Clinical Pharmacology Clinical trials Committees Conflict of Interest Drug Industry - ethics Drugs Drugs and adverse drug reactions Epidemiology/Public Health Evidence Based Practice General Medicine General Practice/Family Practice/Primary Care Gift Giving - ethics Guidelines as Topic Health Policy Humans Marketing - ethics Other Patients Persuasive Communication Pharmaceutical industry Pharmacology/Drug Discovery Physicians Primary Care Public Policy Publishing industry Regulation Scholarly publishing United Kingdom
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Smith explores the implications of a recent report from Britain's House of Commons Health Committee that examined the pharmaceutical industry's influence upon medicine. A recent report from politicians in Britain recommends a fundamental review of drug development, marketing, and prescribing practices
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.0020241